weitere Publikationen in der AG Rimmelzwaan

Prof. Dr. Guus Rimmelzwaan

Beicht, J. (2023). Characterization of Langat virus- and vector-based vaccine approaches against tick-borne encephalitis virus. https://elib.tiho-hannover.de/receive/tiho_mods_00009397
Details anzeigen
Kubinski, M., Beicht, J., Zdora, I., Saletti, G., Kircher, M., Petry-Gusmag, M., Steffen, I., Puff, C., Jung, K., Baumgärtner, W., Rimmelzwaan, G. F., Osterhaus, A. D. M. E., & Prajeeth, C. K. (2023). Cross-reactive antibodies against Langat virus protect mice from lethal tick-borne encephalitis virus infection. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1134371
Details anzeigen
Meineke, R., Stelz, S., Busch, M., Werlein, C., Kühnel, M., Jonigk, D., Rimmelzwaan, G. F., & Elbahesh, H. (2023). FDA-approved Abl/EGFR/PDGFR kinase inhibitors show potent efficacy against pandemic and seasonal influenza A virus infections of human lung explants. IScience, 26(4). https://doi.org/10.1016/j.isci.2023.106309
Details anzeigen
Wilken, L., Stelz, S., Agac, A., Sutter, G., Prajeeth, C. K., & Rimmelzwaan, G. F. (2023). Recombinant modified vaccinia virus Ankara expressing a glycosylation mutant of dengue virus NS1 induces specific antibody and T-cell responses in mice. Vaccines: Open Access Journal, 11(4). https://doi.org/10.3390/vaccines11040714
Details anzeigen
Wilken, L., Stelz, S., Prajeeth, C. K., & Rimmelzwaan, G. F. (2023). Transient Blockade of Type I Interferon Signalling Promotes Replication of Dengue Virus Strain D2Y98P in Adult Wild-Type Mice. Viruses, 15(4). https://doi.org/10.3390/v15040814
Details anzeigen
Zaeck, L. M., Lamers, M. M., Verstrepen, B. E., Bestebroer, T. M., van Royen, M. E., Götz, H., Shamier, M. C., van Leeuwen, L. P. M., Schmitz, K. S., Alblas, K., van Efferen, S., Bogers, S., Scherbeijn, S., Rimmelzwaan, G. F., van Gorp, E. C. M., Koopmans, M. P. G., Haagmans, B. L., GeurtsvanKessel, C. H., & de Vries, R. D. (2023). Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals. Nature Medicine, 29(1), 270–278. https://doi.org/10.1038/s41591-022-02090-w
Details anzeigen
Jansen, J. M. (2022). T cell-mediated immunity to influenza virus and SARS-CoV-2: effect of host adaptation and aging. https://elib.tiho-hannover.de/receive/tiho_mods_00007690
Details anzeigen
Jonczyk, R., Stanislawski, N., Seiler, L. K., Ahani, S., Bueltemeier, A., Stahl, F., Beutel, S., Blume, H., Hauß, C., Melk, A., Paulsen, M., Stiesch, M., Winkel, A., Pott, P.-C., Saletti, G., González-Hernández, M., Kaiser, F. K., Rimmelzwaan, G. F., Osterhaus, A. D. M. E., & Blume, C. (2022). Comparison of two antibody screening systems for SARS-CoV-2 antibody detection in recovered and vaccinated subjects - test performance and possible indicators for immunity. Journal of Clinical Virology, 157. https://doi.org/10.1016/j.jcv.2022.105322
Details anzeigen
Jonczyk, R., Stanislawski, N., Seiler, L. K., Blume, H., Heiden, S., Lucas, H., Sarikouch, S., Pott, P.-C., Stiesch, M., Hauß, C., Saletti, G., González-Hernández, M., Kaiser, F. K., Rimmelzwaan, G., Osterhaus, A., & Blume, C. (2022). Combined prospective seroconversion and PCR data of selected cohorts indicate a high rate of subclinical SARS-CoV-2 infections: an open observational study in Lower Saxony, Germany. Microbiology Spectrum, 10(1). https://doi.org/10.1128/spectrum.01512-21
Details anzeigen
Lombardo, M. S., De la Roi, M., Postel, A., King, J., Kaiser, F., K., Kennedy, J., Reineking, W., Harder, T., Pohlmann, A., Gerlach, T., Rimmelzwaan, G., Rohner, S., Striewe, L. C., Gross, S., Schick, L. A., Klink, J. C., Kramer, K., Osterhaus, A. D. M. E., Beer, M., … Baumgärtner, W. (2022). Infektion des zentralen Nervensystems mit aviärem Influenza-A-Virus des Subtyps H5N8 in Seehunden (Phoca vitulina) an der deutschen Nordseeküste. In Tierärztliche Praxis / G. Thieme. https://doi.org/10.1055/s-0042-1749978
Details anzeigen

Prajeeth K. Chittappen, PhD

Kubinski, M., Beicht, J., Zdora, I., Saletti, G., Kircher, M., Petry-Gusmag, M., Steffen, I., Puff, C., Jung, K., Baumgärtner, W., Rimmelzwaan, G. F., Osterhaus, A. D. M. E., & Prajeeth, C. K. (2023). Cross-reactive antibodies against Langat virus protect mice from lethal tick-borne encephalitis virus infection. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1134371
Details anzeigen
Pilchová, V., Prajeeth, C. K., Jendrny, P., Twele, F., Meller, S., Pink, I., Fathi, A., Addo, M. M., Volk, H. A., Osterhaus, A., Köckritz-Blickwede, M. von, & Schulz, C. (2023). β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: in vitro validation with focus on saliva from COVID-19 patients for scent dog training. Journal of Virological Methods, 317, 114733. https://doi.org/10.1016/j.jviromet.2023.114733
Details anzeigen
Wilken, L., Stelz, S., Agac, A., Sutter, G., Prajeeth, C. K., & Rimmelzwaan, G. F. (2023). Recombinant modified vaccinia virus Ankara expressing a glycosylation mutant of dengue virus NS1 induces specific antibody and T-cell responses in mice. Vaccines: Open Access Journal, 11(4). https://doi.org/10.3390/vaccines11040714
Details anzeigen
Wilken, L., Stelz, S., Prajeeth, C. K., & Rimmelzwaan, G. F. (2023). Transient Blockade of Type I Interferon Signalling Promotes Replication of Dengue Virus Strain D2Y98P in Adult Wild-Type Mice. Viruses, 15(4). https://doi.org/10.3390/v15040814
Details anzeigen
Michaely, L. M., Schuwerk, L., Allnoch, L., Schön, K., Waltl, I., Larsen, P.-K., Pavlou, A., Prajeeth, C. K., Rimmelzwaan, G. F., Becker, S. C., Kalinke, U., Baumgärtner, W., & Gerhauser, I. (2022). Intact type I interferon receptor signaling prevents hepatocellular necrosis but not encephalitis in a dose-dependent manner in Rift Valley fever virus infected mice. International Journal of Molecular Sciences, 23(20). https://doi.org/10.3390/ijms232012492
Details anzeigen
Petry, M., Palus, M., Leitzen, E., Mitterreiter, J. G., Huang, B., Kröger, A., Verjans, G. M. G. M., Baumgärtner, W., Rimmelzwaan, G. F., Růžek, D., Osterhaus, A., & Prajeeth, C. K. (2021). Immunity to TBEV related flaviviruses with reduced pathogenicity protects mice from disease but not from TBEV entry into the CNS. Vaccines: Open Access Journal, 9(3: 196). https://doi.org/10.3390/vaccines9030196
Details anzeigen
Kronenberg, J., Pars, K., Brieskorn, M., Prajeeth, C. K., Heckers, S., Schwenkenbecher, P., Skripuletz, T., Pul, R., Pavlou, A., & Stangel, M. (2019). Fumaric acids directly influence gene expression of neuroprotective factors in rodent microglia. International Journal of Molecular Sciences, 20(2: 325). https://doi.org/10.3390/ijms20020325
Details anzeigen
Pars, K., Gingele, M., Kronenberg, J., Prajeeth, C. K., Skripuletz, T., Pul, R., Jacobs, R., Gudi, V., & Stangel, M. (2019). Fumaric acids do not directly influence gene expression of neuroprotective factors in highly purified rodent astrocytes. Brain Sciences, 9(9: 241). https://doi.org/10.3390/brainsci9090241
Details anzeigen

Husni Elhabesh, PhD

Meineke, R., Stelz, S., Busch, M., Werlein, C., Kühnel, M., Jonigk, D., Rimmelzwaan, G. F., & Elbahesh, H. (2023). FDA-approved Abl/EGFR/PDGFR kinase inhibitors show potent efficacy against pandemic and seasonal influenza A virus infections of human lung explants. IScience, 26(4). https://doi.org/10.1016/j.isci.2023.106309
Details anzeigen
Meineke, R. (2022). Inhibition of Host Kinase Activity: Effects on Influenza A Virus Infection and Host Cell Signaling. https://elib.tiho-hannover.de/receive/tiho_mods_00007171
Details anzeigen
Meineke, R., Stelz, S., Busch, M., Werlein, C., Kühnel, M., Jonigk, D., Rimmelzwaan, G. F., & Elbahesh, H. (2022). FDA-approved inhibitors of RTK/Raf signaling potently impair multiple steps of in vitro and ex vivo influenza A virus infections. Viruses, 14(9). https://doi.org/10.3390/v14092058
Details anzeigen
Becker, T., Elbahesh, H., Reperant, L. A., Rimmelzwaan, G. F., & Osterhaus, A. D. M. E. (2021). Influenza vaccines: successes and continuing challenges. The Journal of Infectious Diseases, 224(Supplement 4), 405-S419. https://doi.org/10.1093/infdis/jiab269
Details anzeigen
Palacios-Pedrero, M. Á., Osterhaus, A. D. M. E., Becker, T., Elbahesh, H., Rimmelzwaan, G. F., & Saletti, G. (2021). Aging and options to halt declining immunity to virus infections. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.681449
Details anzeigen
Ricke-Hoch, M., Stelling, E., Lasswitz, L., Gunesch, A. P., Kasten, M., Zapatero-Belinchón, F. J., Brogden, G., Gerold, G., Pietschmann, T., Montiel, V., Balligand, J.-L., Facciotti, F., Hirsch, E., Gausepohl, T., Elbahesh, H., Rimmelzwaan, G. F., Höfer, A., Kühnel, M. P., Jonigk, D., … Hilfiker-Kleiner, D. (2021). Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease. PLOS ONE, 16(8). https://doi.org/10.1371/journal.pone.0255335
Details anzeigen
Di, H., Elbahesh, H., & Brinton, M. A. (2020). Characteristics of human OAS1 isoform proteins. Viruses, 12(2: 152). https://doi.org/10.3390/v12020152
Details anzeigen
Meineke, R., Werlein, C., Kühnel, M., Jonigk, D., Rimmelzwaan, G. F., & Elbahesh, H. (2020). Differential susceptibility of pandemic H1N1 and seasonal H3N2 Influenza A viruses to clinically-approved small molecule kinase inhibitors. In Stiftung Tierärztliche Hochschule Hannover (Ed.), 13th Graduate School Days: 20/21 November 2020 / Stiftung Tierärztliche Hochschule Hannover. Stiftung Tierärztliche Hochschule Hannover.
Details anzeigen
Saletti, G., Gerlach, T., Jansen, J. M., Molle, A., Elbahesh, H., Ludlow, M., Li, W., Bosch, B.-J., Osterhaus, A. D. M. E., & Rimmelzwaan, G. F. (2020). Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63. Scientific Reports, 10: 21447. https://doi.org/10.1038/s41598-020-78506-9
Details anzeigen
Bergmann, S., & Elbahesh, H. (2019). Targeting the proviral host kinase, FAK, limits influenza a virus pathogenesis and NFkB-regulated pro-inflammatory responses. Virology, 534, 54–63. https://doi.org/10.1016/j.virol.2019.05.020
Details anzeigen